Here Is What Happened When 50 Nonverbal Autistic Children Were Given Pharmaceutical-Grade Folinic Acid For 12 Weeks

In 2018 a team of researchers conducted a clinical trial that should have changed the standard of care for nonverbal autistic children forever.

50 children. Nonverbal. Autistic. Given pharmaceutical-grade folinic acid for 12 weeks.

The results were unlike anything the research team had ever seen before.

The study was published in Molecular Psychiatry. One of the most respected peer-reviewed neuroscience journals in the world.

And then something happened. The phones started ringing. Not from parents. From the industry.

Within months of the trial results being published, pharmaceutical-grade folinic acid began appearing on supplement shelves across the country.

Parents were finding it. Sharing it. Reporting results in Facebook groups that were growing by thousands of members every week. Children were starting to talk. The groups were getting too big. Too loud. Too much evidence in one place of something that actually worked.

CVS received a call.

We do not know exactly who made it. We know the result.

The official reason given was supply chain issues.

The actual reason was a $47 billion industry that makes its money selling you things that manage symptoms rather than address causes — looking at a compound that could not be patented, could not be marked up 4000%, and could not be controlled.

You cannot patent a naturally occurring compound. But you can make it disappear from every major retailer.

Let us be very clear about something. The autism supplement industry is a $2.8 billion market. It is built entirely on products that address the output side of a delivery problem that nobody in the industry wants you to know about.

Here is how the business model works.

The industry knows the door is locked.

The industry knows there is another door.

The industry does not want you to find the other door because the other door costs them $2.8 billion a year. So they took folinic acid off the shelves. They buried the research in journals parents do not read. And they sent their representatives into autism groups to discredit any parent who started talking about the 2018 trial.

Your child's brain builds language pathways from raw materials. The primary raw material is folate — Vitamin B9. The brain cannot manufacture it. It has to be transported from the bloodstream across the blood-brain barrier every single day by specialized carrier proteins.

When FRAAs block the carrier proteins, the folate cannot cross. The brain receives almost none of its primary building material. The language pathways cannot build. The motor planning pathways cannot build. The regulatory pathways cannot build.

This is not a language problem. This is a delivery failure.

Methylfolate requires those blocked carrier proteins. Folic acid requires them. Every supplement the industry has been selling you for years requires the very proteins that have been blocked since before your child's second birthday.

The children who tested positive for FRAAs showed the largest gains of all. Because they were the ones whose door had been most completely locked. And folinic acid was the key that bypassed the lock entirely.

The trial results were submitted to clinical guideline committees. The committees said they needed more research before updating the standard of care.

The standard of care has not been updated. Your child has been waiting.

Before CVS pulled it from the shelves a small group of parents found the trial. They found the pharmaceutical-grade folinic acid. They ordered it. They gave it to their children.

And the Facebook groups started filling up with things nobody had ever seen before.

A mother in Ohio whose seven year old nonverbal son said mama for the first time at week eight. A father in Texas whose five year old daughter who had never produced a functional word said juice standing at the refrigerator at week six. A grandmother in Florida who had been told her grandson would never speak who watched him say I hungry at the breakfast table at week ten.

The groups grew. The posts were shared thousands of times. The industry noticed. The groups started getting taken down. The posts started getting flagged. The CVS shelves went empty.

And the parents who had found it before it disappeared quietly kept ordering from the one source that had not been shut down yet.

Cerevia is pharmaceutical-grade folinic acid formulated to match the exact protocol of the 2018 trial. The bypass form. The one that uses transport pathways that FRAAs cannot block.

Combined with active methylcobalamin B12 to drive the methylation cycle. Active pyridoxal-5-phosphate B6 for the neurotransmitter synthesis that language development depends on. Active riboflavin-5-phosphate B2 to power the entire chain.

We are not hiding it. We are not pulling it from shelves. We are making it available directly to parents who have been waiting long enough.